Enlivex Therapeutics Ltd (ENLV)
NASDAQ:ENLV
Holding ENLV?
Track your performance easily

Enlivex (ENLV) Financial Statements

395 Followers

Enlivex Financial Overview

Enlivex's market cap is currently ―. The company's EPS TTM is $-1.189; its P/E ratio is -1.00; Enlivex is scheduled to report earnings on May 23, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT--$ -5.68M$ -5.87M$ -6.40M
EBITDA--$ -5.49M$ -5.70M$ -6.22M
Net Income Common Stockholders--$ -5.73M$ -9.91M$ -8.22M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 27.32M$ 50.24M$ 38.55M$ 62.48M$ 78.00M
Total Assets$ 36.83M$ 67.64M$ 72.41M$ 77.34M$ 88.62M
Total Debt$ 346.00K$ 4.19M$ 5.26M$ 629.00K$ 694.00K
Net Debt$ -26.97M$ -46.05M$ -33.29M$ -61.86M$ -77.31M
Total Liabilities$ 6.75M$ 10.80M$ 9.14M$ 8.86M$ 10.97M
Stockholders Equity$ 30.08M$ 56.84M$ 63.27M$ 68.49M$ 77.65M
Cash Flow-
Free Cash Flow--$ -7.78M$ -12.67M$ -4.22M
Operating Cash Flow--$ -6.59M$ -9.27M$ -3.27M
Investing Cash Flow--$ 44.04M$ -38.32M$ 59.67M
Financing Cash Flow--$ 50.00K$ 50.00K$ 50.00K
Currency in USD

Enlivex Earnings and Revenue History

Enlivex Debt to Assets

Enlivex Cash Flow

Enlivex Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis